Target intelligence / Profile preview

RN7SK pseudogene 52 (RN7SKP52)

Target
RN7SKP52
Molecular classification
Other (pseudogene, noncoding RNA)
01

Overview

RN7SK pseudogene 52 (RN7SKP52) is a predicted non-coding RNA gene categorized as a *pseudogene* of the functional RN7SK small nuclear RNA (snRNA) gene. Pseudogenes, by definition, are generally non-functional remnants of genes that have lost their ability to encode functional RNAs or proteins, usually due to mutations or truncations. Unlike the functional RN7SK snRNA, which plays a well-established regulatory role in controlling RNA polymerase II pausing and transcription via the 7SK snRNP complex[1][2][3], RN7SKP52 is not transcribed into a functional product, has no documented biological activity, and does not serve as a molecular drug or disease target. Therefore, it is not recognized as a therapeutically actionable site or relevant to pharmacological intervention. - The functional RN7SK snRNA is involved in cell cycle control, cellular differentiation (notably in the epidermis), and regulation of gene transcription—primarily via interactions with the P-TEFb complex and modulating RNA polymerase II activity[1][2][3]. - However, the pseudogene RN7SKP52 is a genomic artifact and does not participate in these biological pathways. - There is currently no evidence linking RN7SKP52 to disease, druggability, or clinical relevance. Note: If you intended to refer to the functional *RN7SK* gene or snRNA, which does participate in critical transcriptional regulation, please clarify. The pseudogene RN7SKP52 does not share these functional properties.

Other names
RN7SKP52RNA, 7SK small nuclear pseudogene 52

Beyond the preview

Go deeper on RN7SK pseudogene 52 (RN7SKP52).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RN7SK pseudogene 52 (RN7SKP52).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call